Acute promyelocytic leukemia in patients aged 70 years and over—A single center experience of unselected patients
- 1 January 2007
- journal article
- letter
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 48 (8), 1654-1658
- https://doi.org/10.1080/10428190701472005
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Treatment of older patients with AMLCritical Reviews in Oncology/Hematology, 2005
- Disease biology rather than age is the most important determinant of survival of patients ≥ 60 years with acute myeloid leukemia treated with uniform intensive therapyCancer, 2005
- All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemiaBlood, 2004
- Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceLeukemia, 2004
- Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disordersBlood, 2004
- Therapy-Related Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2003
- Treatment of elderly patients (≥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsLeukemia, 2003
- The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 yearsAnnals Of Oncology, 1997
- The "Retinoic Acid Syndrome" in Acute Promyelocytic LeukemiaAnnals of Internal Medicine, 1992
- On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.Journal of Clinical Oncology, 1989